Gelin Biotech announced that the company initially publicly issued 333.33 million RMB common shares and was listed on the GEM. The issued shares accounted for 25.00% of the company's total share capital after issuance, and the total share capital after issuance was 133 million shares. The offering was carried out using a combination of strategic placement, offline distribution, and online distribution. The initial number of strategic placements was 10 million shares, 16.333,300 shares were initially distributed offline, and 7 million shares were initially issued online. The initial inquiry period for this sale is on August 14, 2026 at 9:30-15:00, and the online and offline subscription date is also August 20, 2026.

Gelin Biotech announced that the company initially publicly issued 333.33 million RMB common shares and was listed on the GEM. The issued shares accounted for 25.00% of the company's total share capital after issuance, and the total share capital after issuance was 133 million shares. The offering was carried out using a combination of strategic placement, offline distribution, and online distribution. The initial number of strategic placements was 10 million shares, 16.333,300 shares were initially distributed offline, and 7 million shares were initially issued online. The initial inquiry period for this sale is on August 14, 2026 at 9:30-15:00, and the online and offline subscription date is also August 20, 2026.